Akkermansia

What it is

Akkermansia muciniphila is a species of bacteria that naturally lives in the healthy human gut — specifically in the mucus layer lining the intestine, where it feeds on mucin (the main component of mucus). It typically makes up a few percent of an adult's gut bacteria and has become a popular target for gut-and-metabolic-health supplements.

What it does

• Helps maintain the gut barrier. By grazing on mucus, it stimulates the gut to produce more, supporting a healthy protective layer.
• Associates with metabolic health. Higher levels track with healthier metabolic profiles; lower levels are associated with obesity and type 2 diabetes.
• Shows early promise in trials. A small proof-of-concept human study found a pasteurized form was safe and improved some metabolic markers — notably, the heat-killed "postbiotic" form performed as well as or better than live bacteria.

What it does NOT do

• Association is not proof. Its link to leanness doesn't establish that supplementing reverses obesity or disease — no supplement does.
• It's not "more is always better." Because it consumes the mucus barrier, in some conditions (e.g. active inflammatory bowel disease) boosting it may not help.
• Human evidence is still early and limited. Much of the dramatic data comes from mice, and long-term human data are sparse.

Forms and doses

• Sold as live or, increasingly, pasteurized (postbiotic) preparations; the pasteurized form is more stable and was used in the key human study.
• No universally established consumer dose; follow product guidance and consult a clinician if you have a gut condition, are immunocompromised, pregnant, or recently on antibiotics.

Sources

1. Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers. Nature Medicine, 2019.
2. A critical perspective on the supplementation of Akkermansia muciniphila: benefits and harms. 2023.